TY - JOUR
T1 - Acute exacerbation in rheumatoid arthritis-associated interstitial lung disease
T2 - A retrospective case control study
AU - Hozumi, Hironao
AU - Nakamura, Yutaro
AU - Johkoh, Takeshi
AU - Sumikawa, Hiromitsu
AU - Colby, Thomas V.
AU - Kono, Masato
AU - Hashimoto, Dai
AU - Enomoto, Noriyuki
AU - Fujisawa, Tomoyuki
AU - Inui, Naoki
AU - Suda, Takafumi
AU - Chida, Kingo
PY - 2013
Y1 - 2013
N2 - Objectives: To investigate the risk factors and prognosis associated with acute exacerbation (AE) in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD). Design: A retrospective case-control study. Setting: A single academic hospital. Participants: 51 consecutive patients diagnosed with RA-ILD between 1995 and 2012. All patients fulfilled the diagnostic criteria of the American College of Rheumatology for RA. ILD was diagnosed on the basis of clinical presentation, pulmonary function tests, highresolution CT (HRCT) findings and lung biopsy findings. Main outcome measures: Overall survival and cumulative AE incidence were analysed using KaplanMeier method. Cox hazards analysis was used to determine significant variables associated with AE occurrence and survival status. Results: A total of 11 patients (22%) developed AE, with an overall 1-year incidence of 2.8%. Univariate analysis revealed that older age at ILD diagnosis (HR 1.11; 95% CI 1.02 to 1.21; p=0.01), usual interstitial pneumonia (UIP) pattern on HRCT (HR 1.95; 95% CI 1.07 to 3.63; p=0.03) and methotrexate usage (HR 3.04; 95% CI 1.62 to 6.02; p=0.001) were associated with AE. Of 11 patients who developed AE during observation period, 7 (64%) died of initial AE. In survival, AE was a prognostic factor for poor outcome (HR 2.47; 95% CI 1.39 to 4.56; p=0.003). Conclusions: In patients with RA-ILD, older age at ILD diagnosis, UIP pattern on HRCT and methotrexate usage are associated with the development of AE. Furthermore, AE has a serious impact on their survival.
AB - Objectives: To investigate the risk factors and prognosis associated with acute exacerbation (AE) in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD). Design: A retrospective case-control study. Setting: A single academic hospital. Participants: 51 consecutive patients diagnosed with RA-ILD between 1995 and 2012. All patients fulfilled the diagnostic criteria of the American College of Rheumatology for RA. ILD was diagnosed on the basis of clinical presentation, pulmonary function tests, highresolution CT (HRCT) findings and lung biopsy findings. Main outcome measures: Overall survival and cumulative AE incidence were analysed using KaplanMeier method. Cox hazards analysis was used to determine significant variables associated with AE occurrence and survival status. Results: A total of 11 patients (22%) developed AE, with an overall 1-year incidence of 2.8%. Univariate analysis revealed that older age at ILD diagnosis (HR 1.11; 95% CI 1.02 to 1.21; p=0.01), usual interstitial pneumonia (UIP) pattern on HRCT (HR 1.95; 95% CI 1.07 to 3.63; p=0.03) and methotrexate usage (HR 3.04; 95% CI 1.62 to 6.02; p=0.001) were associated with AE. Of 11 patients who developed AE during observation period, 7 (64%) died of initial AE. In survival, AE was a prognostic factor for poor outcome (HR 2.47; 95% CI 1.39 to 4.56; p=0.003). Conclusions: In patients with RA-ILD, older age at ILD diagnosis, UIP pattern on HRCT and methotrexate usage are associated with the development of AE. Furthermore, AE has a serious impact on their survival.
UR - http://www.scopus.com/inward/record.url?scp=84885400832&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84885400832&partnerID=8YFLogxK
U2 - 10.1136/bmjopen-2013-003132
DO - 10.1136/bmjopen-2013-003132
M3 - Article
C2 - 24038004
AN - SCOPUS:84885400832
SN - 2044-6055
VL - 3
JO - BMJ open
JF - BMJ open
IS - 9
M1 - e003132
ER -